Advertisement

Methodology and Application of Fluorescence Techniques in Dermatology

  • V. Wienert
  • A. Lentner
  • U. Böhler

Abstract

Fluorescein was first made synthetically by the German chemist, Adolf Ritter von Baeyer in 1871 [1]. Baeyer (1835–1917) won the Nobel prize for chemistry in 1905. It was only 10 years after this discovery that the German physician Paul Ehrlich (1854–1915, winner of the Nobel prize for medicine in 1908) introduced fluorescein into diagnostic medicine [14]. Ehrlich injected fluorescein and examined the dependence of the production of aqueous humour in the eye on intraocular pressure. Since then, the use of fluorescent dyes has spread to many fields of medicine.

Keywords

Fluorescence Technique Fluorescein Sodium Chronic Venous Insufficiency Fluorescence Angiography Thromboangiitis Obliterans 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    von Baeyer A (1900) Zur Geschichte der Indigosynthese. Ber Dtsch Chem Ges 33 [Sonderheft]Google Scholar
  2. 2.
    Barry RE. Behrendt WA (1985) Studies on the pharmacokinetics of fluorescein and its dilaurate ester under the conditions of the fluorescein dilaurate test. Arzneimittel Forschung 35: 644–648PubMedGoogle Scholar
  3. 3.
    Baumann HR, Cottier P (1960) Natriumfluorescein zur Bestimmung des Herzminutenvolu- mens mit Hilfe der Dilutionsmethode nach Hamilton-Stewart. Helv Med Acta 27: 18–36PubMedGoogle Scholar
  4. 4.
    Bollinger A, Jäger K (1981) Trans- and pericapillary diffusion of Na-fluorescein in scleroderma and chronic venous insufficiency. Bibl Anat 20: 679–683Google Scholar
  5. 5.
    Bollinger A, Jakob F, Jäger K (1982) Pattern of diffusion through skin capillaries in patients with long-term diabetes. New Engl J Med 307: 1305–1310PubMedCrossRefGoogle Scholar
  6. 6.
    Bollinger A, Franzeck UK, Jäger K (1983) Fluoreszenz-Videomikroskopie zur quantitativen Analyse dynamischer Phanomene in der menschlichen Mikrozirkulation. In: MeBmer K, Hammersen F (eds) Vasomotion und quantitative Kapillaroskopie: Berichte des 2. Bodensee- Symposiums uber Mikrozirkulation, Karger, Basel pp 111–133Google Scholar
  7. 7.
    Chen SC, Nakumura H, Zenzo T (1980) Studies on the metabolites of fluorescein in rabbit and human urine. Chem Pharm Bull (Tokyo) 28: 1403–1407Google Scholar
  8. 8.
    Cipolla A, Khedroo L, Casella P (1953) Fluorescein test for intraperitoneal rupture of the urinary bladder. Surgery 33: 102–106PubMedGoogle Scholar
  9. 9.
    Coons AH, Creech HJ, Jones R N, Berliner E (1942) The demonstration of pneumococcal antigen in tissues by the use of fluorescent antibody. J Immunol 45: 159–170Google Scholar
  10. 10.
    Crismon JM, Fuhrman FA (1947) Studies on gangrene following cold injury. IV. The use of fluorescein as an indicator of local blood flow. Distribution of fluorescein in body fluids after intravenous injection. J Clin Invest 26: 259–267Google Scholar
  11. 11.
    Delori FC, Castany MA, Webb RH (1978) Flurescence characteristics of sodium fluorescein in plasma and whole blood. Exp Eye Res 27: 417–425PubMedCrossRefGoogle Scholar
  12. 12.
    Dollery CT, Hodge JV, Engel M (1962) Studies of the retinal circulation with fluorescein. Br MJ 2: 1210–1215CrossRefGoogle Scholar
  13. 13.
    Dollery CT, Hodge JV, Engel M (1963) Retinal photography using fluorescein. Med Biol III 13: 4–14Google Scholar
  14. 14.
    Ehrlich P (1882) Über provozierte Fluoreszenzerscheinungen am Auge. Dtsch Med Wochenschr 8: 21–22, 35–37, 54–55Google Scholar
  15. 15.
    Enzmann V, Ruprecht KW(1982) Zwischenfälle bei der Fluoreszenzangiographie der Retina. Symptomatik, Prophylaxe undTherapie. Klin Monatsbl Augenheilk 181: 235–236Google Scholar
  16. 16.
    De Haan J, van Creveld S (1921) Uber die Wechselwirkungen zwischen Blutplasma und Gewebeflussigkeiten, insbesondere Kammerwasser und Cerebrospinalflüssigkeit: II. Durchlassigkeit für Fluorescein und Jodsalze. Biochem Z 124: 172–184Google Scholar
  17. 17.
    Hantke U (1986) Chemilumineszente organische Verbindungen. Mechanistische Vorstellun- gen zur Chemilumineszenzreaktion und mögliche Einflußgrdßen auf die Chemilumineszenz dieser Verbindungen. Arztl Lab 32: 1–10Google Scholar
  18. 18.
    Hoffmann U, Franzeck UK, Speiser D, Bollinger A (1990) Mikroangiopathie bei chronischer Veneninsuffizienz. Phlebol Proktol 19: 10–15Google Scholar
  19. 19.
    Isenring G, Franzeck UK, Bollinger A (1982) Lymphatische Mikroangiopathie bei chronisch venöser Insuffizienz ( CVI ). Vasa 11: 104–110Google Scholar
  20. 20.
    Karhunen U, Raitta C, Kala R (1986) Adverse reactions to fluorescein angiography. Acta Ophthalmol 64: 282–286Google Scholar
  21. 21.
    Kramer DW, Abramson EB (1947) Fluorescein studies in peripheral vascular disorders Am J Med Sci 214: 368–371Google Scholar
  22. 22.
    Lange K (1944) The vascular prerequisites to successful skin grafting. Surgery 15: 85–89Google Scholar
  23. 23.
    Lange K, Boyd LJ (1934) The technique of the fluorescein test to determine the adequacy of circulation in peripheral vascular diseases, the circulation time and capillary permeability.Google Scholar
  24. 24.
    Lange K, Boyd LJ (1942) The use of fluorescein to determine the adequacy of the circulation. Med Clin North Am 26: 943–952Google Scholar
  25. 25.
    Lange K, Boyd LJ (1943) The technique of the fluorescein test to determine the adequacy of circulation in peripheral vascular diseases, the circulation time and capillary permeability. Bull NY Med CoU 6: 78–81Google Scholar
  26. 26.
    Lange K, Boyd LJ (1943) Objective methods of determine the speed of blood flow and their results. ( Flurescein and acetylene ). Am J Med Sci 206: 438–448Google Scholar
  27. 27.
    Lange K, Boyd LJ (1944) Use of fluorescein method in establishment of diagnosis and prognosis of peripheral vascular diseases. Arch Intern Med 74: 175–184Google Scholar
  28. 28.
    Lange K, Krewer SE (1943) The dermofluorometer. J Lab Clin Med 28: 1746–1750Google Scholar
  29. 29.
    Laurence DJR (1952) A study of the adsorption of dyes on bovine serum albumin by the method of polarization of fluorescence. Biochem J 51: 168–180PubMedGoogle Scholar
  30. 30.
    Liegl O, Mehring M (1970) Der Weg des Fluoreszeinnatriums durch die Horahaut. Klin Monatsbl Augenheilk 159: 219–221Google Scholar
  31. 31.
    Lund F, Lund S (1973) Dynamic fluorescein angiography. Anew method for assessment of skin circulation of the limbs in peripheral arterial disease. In: Shimamoto T et al (eds) Athero- genesis II. Proceedings of the 2nd international symposium on: thrombogenesis and pyri- dionalcarbamate treatment, Tokyo 1972. Excerpta Med Int Congr Ser 269: 336–346Google Scholar
  32. 32.
    McEnerney JK, Wong WP, Peyman GA (1977) Evaluation of the teratogenicity of fluorescein sodium. Am J Ophthalmol 84. 847–850PubMedGoogle Scholar
  33. 33.
    Marcus DF, Bovino JA, Williams D (1984) Adverse reactions during intravenous fluorescein angiography. Arch Ophthalmol 102: 825PubMedGoogle Scholar
  34. 34.
    Mecklenburg W, Valentiner S (1914) Uber die Abhangigkeit der Fluoreszenz von der Konzentration. Physikal Z 15: 267–274Google Scholar
  35. 35.
    Neller JL, Schmidt ER (1945) Wheal-fluorescence. A new method of evaluating peripheral vascular diseases. Ann Surg 121: 328–337Google Scholar
  36. 36.
    Novotny HR, Alvis DL (1961) A method of photographing fluorescence in circulating blood of the human retina. Circulation 24: 82–86PubMedGoogle Scholar
  37. 37.
    Scheffler A, Rieger H (1989) Ein Bildverarbeitungssystem fur den klinischen Einsatz der digitalen Videofluoreszenzperfusographie. Vasa Suppl 27: 86–87Google Scholar
  38. 38.
    Silverman DG, Larossa DD, Barlow CH, BeringTG, Popky LM, SmithTC (1980) Quantifi-cation of tissue fluorescein delivery and prediction of flap viability with the fiberoptic dermofluorometer. Plast Reconstr Surg 66: 545–553PubMedCrossRefGoogle Scholar
  39. 39.
    Stein MR, Parker CW (1971) Reactions following intravenous fluorescein. Am J Ophthalmol 72: 861–868PubMedGoogle Scholar
  40. 40.
    Strauss H (1913) Fluorescein als Indikator fur die Nierenfunktion. Berl Klin Woschenschr 50: 2226–2227Google Scholar
  41. 41.
    Webb JM, Fonda M, Brouwer EA (1962) Metabolism and excretion patterns of fluorescein and certain halogenated fluorescein dyes in rats. J Pharmacol Exp Ther 137: 141–147PubMedGoogle Scholar
  42. 42.
    Weiye L, Rockey JH (1982) Fluorescein binding to normal human serum proteins demon-strated by equlibrium dialysis. Arch Ophthalmol 100: 484–487Google Scholar
  43. 43.
    Wessing A (1968) Fluoreszenzangiographie der Retina. Lehrbuch und Atlas. Thieme, Stuttgart, pp 8–9Google Scholar
  44. 44.
    Yannuzzi LA, Rohrer KT, Tindel LJ, Sobel RS, Costanza MA, Shields W, Zang E (1986) Fluorescein angiography complication survey. Ophthalmology 93: 611–617PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • V. Wienert
  • A. Lentner
  • U. Böhler
    • 1
  1. 1.Department of DermatologyMedical Faculty of the University of Aachen, Division of Dermatological PhlebologyAachenGermany

Personalised recommendations